Biofil Net Receivables vs Non Current Liabilities Total Analysis

BIOFILCHEM

62.15 2.39 4.00%

Biofil Chemicals financial indicator trend analysis is way more than just evaluating Biofil Chemicals Pha prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofil Chemicals Pha is a good investment. Please check the relationship between Biofil Chemicals Net Receivables and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Net Receivables vs Non Current Liabilities Total

Net Receivables vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofil Chemicals Pha Net Receivables account and Non Current Liabilities Total. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Biofil Chemicals' Net Receivables and Non Current Liabilities Total is -0.24. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Biofil Chemicals Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Biofil Chemicals' Net Receivables and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Biofil Chemicals Pharmaceuticals are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Net Receivables i.e., Biofil Chemicals' Net Receivables and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Receivables

Non Current Liabilities Total

Most indicators from Biofil Chemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofil Chemicals Pha current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

The current year's Selling General Administrative is expected to grow to about 7 M. The current year's Tax Provision is expected to grow to about 2.4 M

	2021	2022	2023	2024 (projected)
Gross Profit	29.2M	21.4M	25.3M	21.7M
Total Revenue	223.8M	300.4M	400.4M	420.4M

Gross Profit Total Revenue

Biofil Chemicals fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Short Term Debt	Other Liab	Net Tangible Assets
Common Stock Shares Outstanding		-0.39	0.71	-0.18	-0.31	-0.62	-0.77	0.6	-0.29	-0.25	-0.15	-0.66	0.04	-0.16	-0.34	0.99	-0.23	-0.14	0.44	-0.18	-0.34	-0.92	0.04	0.27	-0.25	-0.33
Total Assets	-0.39		-0.73	0.36	0.82	0.81	0.37	-0.75	0.54	0.83	0.47	0.35	-0.27	0.47	0.86	-0.33	0.67	0.42	-0.75	0.8	0.86	0.57	-0.37	-0.72	0.69	0.83
Short Long Term Debt Total	0.71	-0.73		-0.18	-0.61	-0.93	-0.64	0.93	-0.64	-0.61	-0.44	-0.59	0.02	-0.44	-0.73	0.61	-0.66	-0.11	0.87	-0.54	-0.74	-0.76	0.09	0.87	-0.73	-0.85
Other Current Liab	-0.18	0.36	-0.18		0.31	0.27	0.59	-0.12	0.01	0.3	-0.04	0.65	-0.65	-0.04	0.31	-0.21	0.1	0.68	-0.41	0.29	0.28	0.13	-0.89	-0.11	0.35	0.23
Total Current Liabilities	-0.31	0.82	-0.61	0.31		0.52	0.39	-0.77	0.34	1.0	0.76	0.41	-0.24	0.76	0.97	-0.23	0.66	0.35	-0.61	0.99	0.97	0.53	-0.3	-0.6	0.65	0.59
Total Stockholder Equity	-0.62	0.81	-0.93	0.27	0.52		0.55	-0.83	0.7	0.54	0.31	0.5	-0.16	0.31	0.67	-0.54	0.63	0.21	-0.88	0.46	0.68	0.69	-0.19	-0.84	0.75	0.94
Property Plant And Equipment Net	-0.77	0.37	-0.64	0.59	0.39	0.55		-0.52	0.19	0.35	0.1	0.99	-0.45	0.1	0.41	-0.75	0.42	0.46	-0.59	0.29	0.41	0.64	-0.53	-0.32	0.45	0.35
Net Debt	0.6	-0.75	0.93	-0.12	-0.77	-0.83	-0.52		-0.53	-0.77	-0.74	-0.48	0.01	-0.74	-0.85	0.48	-0.72	-0.03	0.81	-0.71	-0.87	-0.77	0.03	0.84	-0.77	-0.83
Retained Earnings	-0.29	0.54	-0.64	0.01	0.34	0.7	0.19	-0.53		0.37	0.14	0.15	-0.1	0.14	0.51	-0.19	0.39	-0.02	-0.51	0.33	0.5	0.32	0.01	-0.71	0.65	0.7
Accounts Payable	-0.25	0.83	-0.61	0.3	1.0	0.54	0.35	-0.77	0.37		0.76	0.38	-0.23	0.77	0.98	-0.16	0.68	0.33	-0.63	1.0	0.98	0.47	-0.3	-0.65	0.68	0.62
Cash	-0.15	0.47	-0.44	-0.04	0.76	0.31	0.1	-0.74	0.14	0.76		0.11	0.03	1.0	0.74	-0.04	0.54	-0.14	-0.39	0.77	0.77	0.48	0.11	-0.47	0.54	0.45
Non Current Assets Total	-0.66	0.35	-0.59	0.65	0.41	0.5	0.99	-0.48	0.15	0.38	0.11		-0.52	0.11	0.42	-0.63	0.46	0.51	-0.6	0.33	0.43	0.53	-0.61	-0.33	0.49	0.34
Non Currrent Assets Other	0.04	-0.27	0.02	-0.65	-0.24	-0.16	-0.45	0.01	-0.1	-0.23	0.03	-0.52		0.03	-0.2	0.04	-0.28	-0.69	0.2	-0.24	-0.2	-0.03	0.79	0.01	-0.46	-0.18
Cash And Short Term Investments	-0.16	0.47	-0.44	-0.04	0.76	0.31	0.1	-0.74	0.14	0.77	1.0	0.11	0.03		0.74	-0.04	0.55	-0.14	-0.39	0.77	0.77	0.48	0.11	-0.48	0.54	0.45
Net Receivables	-0.34	0.86	-0.73	0.31	0.97	0.67	0.41	-0.85	0.51	0.98	0.74	0.42	-0.2	0.74		-0.24	0.69	0.31	-0.74	0.96	1.0	0.55	-0.25	-0.76	0.76	0.74
Non Current Liabilities Total	0.99	-0.33	0.61	-0.21	-0.23	-0.54	-0.75	0.48	-0.19	-0.16	-0.04	-0.63	0.04	-0.04	-0.24		-0.12	-0.2	0.36	-0.09	-0.23	-0.88	0.07	0.14	-0.11	-0.23
Inventory	-0.23	0.67	-0.66	0.1	0.66	0.63	0.42	-0.72	0.39	0.68	0.54	0.46	-0.28	0.55	0.69	-0.12		0.08	-0.66	0.65	0.74	0.37	-0.29	-0.72	0.77	0.72
Other Current Assets	-0.14	0.42	-0.11	0.68	0.35	0.21	0.46	-0.03	-0.02	0.33	-0.14	0.51	-0.69	-0.14	0.31	-0.2	0.08		-0.35	0.33	0.27	0.06	-0.7	-0.05	0.17	0.17
Other Stockholder Equity	0.44	-0.75	0.87	-0.41	-0.61	-0.88	-0.59	0.81	-0.51	-0.63	-0.39	-0.6	0.2	-0.39	-0.74	0.36	-0.66	-0.35		-0.57	-0.75	-0.51	0.33	0.86	-0.73	-0.89
Total Liab	-0.18	0.8	-0.54	0.29	0.99	0.46	0.29	-0.71	0.33	1.0	0.77	0.33	-0.24	0.77	0.96	-0.09	0.65	0.33	-0.57		0.96	0.41	-0.3	-0.6	0.65	0.57
Total Current Assets	-0.34	0.86	-0.74	0.28	0.97	0.68	0.41	-0.87	0.5	0.98	0.77	0.43	-0.2	0.77	1.0	-0.23	0.74	0.27	-0.75	0.96		0.55	-0.24	-0.77	0.78	0.76
Common Stock	-0.92	0.57	-0.76	0.13	0.53	0.69	0.64	-0.77	0.32	0.47	0.48	0.53	-0.03	0.48	0.55	-0.88	0.37	0.06	-0.51	0.41	0.55		0.0	-0.39	0.4	0.49
Current Deferred Revenue	0.04	-0.37	0.09	-0.89	-0.3	-0.19	-0.53	0.03	0.01	-0.3	0.11	-0.61	0.79	0.11	-0.25	0.07	-0.29	-0.7	0.33	-0.3	-0.24	0.0		0.09	-0.37	-0.2
Short Term Debt	0.27	-0.72	0.87	-0.11	-0.6	-0.84	-0.32	0.84	-0.71	-0.65	-0.47	-0.33	0.01	-0.48	-0.76	0.14	-0.72	-0.05	0.86	-0.6	-0.77	-0.39	0.09		-0.83	-0.93
Other Liab	-0.25	0.69	-0.73	0.35	0.65	0.75	0.45	-0.77	0.65	0.68	0.54	0.49	-0.46	0.54	0.76	-0.11	0.77	0.17	-0.73	0.65	0.78	0.4	-0.37	-0.83		0.85
Net Tangible Assets	-0.33	0.83	-0.85	0.23	0.59	0.94	0.35	-0.83	0.7	0.62	0.45	0.34	-0.18	0.45	0.74	-0.23	0.72	0.17	-0.89	0.57	0.76	0.49	-0.2	-0.93	0.85

Click cells to compare fundamentals

Biofil Chemicals Account Relationship Matchups

Biofil Chemicals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	423.6M	332.4M	187.3M	314.1M	470.8M	242.1M
Short Long Term Debt Total	11.9M	4.3M	4.6M	5.2M	4.4M	4.2M
Other Current Liab	15.6M	1.4M	1.6M	933K	2.9M	3.9M
Total Current Liabilities	274.8M	167.5M	14.9M	137.3M	285.2M	299.5M
Total Stockholder Equity	148.8M	161.3M	168.4M	173.0M	182.0M	119.5M
Property Plant And Equipment Net	100.9M	97.8M	94.2M	90.0M	86.2M	99.3M
Net Debt	9.4M	(107K)	3.2M	5.0M	(18.4M)	(17.5M)
Retained Earnings	(350.1M)	(337.7M)	(330.6M)	(128.5M)	(318.3M)	(334.2M)
Accounts Payable	259.2M	158.5M	6.0M	126.5M	275.5M	289.3M
Cash	2.6M	4.4M	1.5M	260K	22.8M	24.0M
Non Current Assets Total	100.9M	97.8M	94.2M	90.0M	86.8M	99.9M
Non Currrent Assets Other	(100.9M)	(37K)	(191K)	(307K)	508K	533.4K
Cash And Short Term Investments	2.6M	4.4M	1.5M	377K	22.8M	24.0M
Net Receivables	299.2M	186.0M	71.8M	205.0M	330.3M	346.8M
Liabilities And Stockholders Equity	423.6M	332.4M	187.3M	314.1M	470.8M	242.1M
Inventory	16.9M	43.4M	12.9M	12.1M	25.5M	26.8M
Other Current Assets	303.2M	793K	7.0M	6.5M	5.5M	5.2M
Total Liab	274.8M	171.1M	18.9M	141.0M	288.8M	303.2M
Total Current Assets	322.7M	234.6M	93.1M	224.1M	384.1M	403.3M
Current Deferred Revenue	(11.9M)	(4.3M)	4.3M	2.3M	1.4M	1.5M
Short Term Debt	11.9M	4.3M	4.6M	2.9M	4.4M	4.2M
Net Tangible Assets	136.5M	148.8M	161.3M	168.4M	193.6M	140.0M
Short Long Term Debt	11.9M	4.3M	4.6M	5.2M	4.4M	4.2M
Property Plant Equipment	100.9M	97.8M	94.2M	90.0M	103.5M	103.6M
Net Invested Capital	160.8M	165.6M	173.0M	178.2M	186.4M	182.9M
Cash And Equivalents	2.6M	4.4M	1.4M	260K	234K	222.3K
Net Working Capital	47.9M	67.1M	78.2M	86.8M	98.8M	71.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Biofil Stock

Balance Sheet is a snapshot of the financial position of Biofil Chemicals Pha at a specified time, usually calculated after every quarter, six months, or one year. Biofil Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biofil Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biofil currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biofil Net Receivables vs Non Current Liabilities Total Analysis

Net Receivables vs Non Current Liabilities Total

Net Receivables vs Non Current Liabilities Total Correlation Analysis

Correlation Coefficient

Net Receivables

Non Current Liabilities Total

Biofil Chemicals fundamental ratios Correlations

Biofil Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biofil Chemicals fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Biofil Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Accounts Payable	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Accounts Payable
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Net Receivables
Non Current Liabilities Total	+ 0.99	Common Stock Shares Outstanding
Total Liab	+ 0.99	Total Current Liabilities

Net Tangible Assets	- 0.93	Short Term Debt
Total Stockholder Equity	- 0.93	Short Long Term Debt Total
Common Stock	- 0.92	Common Stock Shares Outstanding
Net Tangible Assets	- 0.89	Other Stockholder Equity
Current Deferred Revenue	- 0.89	Other Current Liab
Common Stock	- 0.88	Non Current Liabilities Total